These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery. Sternberg A; McKee DL; Naujokat C Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679 [TBL] [Abstract][Full Text] [Related]
4. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses. Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955 [TBL] [Abstract][Full Text] [Related]
5. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy. Goyal B; Goyal D ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186 [TBL] [Abstract][Full Text] [Related]
6. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
8. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera. Jairajpuri MA; Ansari S Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854 [TBL] [Abstract][Full Text] [Related]
9. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Fintelman-Rodrigues N; Sacramento CQ; Ribeiro Lima C; Souza da Silva F; Ferreira AC; Mattos M; de Freitas CS; Cardoso Soares V; da Silva Gomes Dias S; Temerozo JR; Miranda MD; Matos AR; Bozza FA; Carels N; Alves CR; Siqueira MM; Bozza PT; Souza TML Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32759267 [TBL] [Abstract][Full Text] [Related]
10. Biochemical screening for SARS-CoV-2 main protease inhibitors. Coelho C; Gallo G; Campos CB; Hardy L; Würtele M PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015 [TBL] [Abstract][Full Text] [Related]
11. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
12. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991 [TBL] [Abstract][Full Text] [Related]
13. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study. Gentile D; Patamia V; Scala A; Sciortino MT; Piperno A; Rescifina A Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32340389 [TBL] [Abstract][Full Text] [Related]
14. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
19. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov. Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. Wang S; Li W; Hui H; Tiwari SK; Zhang Q; Croker BA; Rawlings S; Smith D; Carlin AF; Rana TM EMBO J; 2020 Nov; 39(21):e106057. PubMed ID: 32944968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]